Miami-based eMed, which focuses on health management for the GLP-1 and GIP population, said Yaccarino’s experience will be critical as it expands its services to accommodate new employers and government partnerships.

Though Yaccarino does not have experience in health tech, eMed said in a press release that they sought her out for her "undeniable ability to negotiate new partnerships."

Linda Yaccarino, the former X CEO who left the social media company last month in the wake of yet another Elon Musk controversy, has been named the top executive at health company eMed. eMed Population Health provides support for patients on GLP-1 medications,